Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Quick Stats
May 13, 202666.0
AI Score
BUY0.95
Volume Ratio
May 05, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
JAZZ Stock Summary
Last updated May 13, 2026
JAZZ is currently trading at $232.33, positioned above its 200-day moving average of $160.7, indicating a long-term uptrend. The stock has a 52-week range of $101.5 to $235.
Technical Analysis: The 50-day moving average stands at $196.23, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 74.819, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.071, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates JAZZ at 66.0/100 with a BUY recommendation.
JAZZ (Jazz Pharmaceuticals, Inc.) Indicators
Last updated May 13, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 74.819 |
| CMF (20) | 0.071 |
| ROC (10) | 16.211 |
| ADX (14) | 45.115 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 9.739 |
| AROONOSC (14) | 92.857 |
| WILLAMS %R (14) | -6.637 |
| MFI (14) | 74.172 |
JAZZ Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
JAZZ Price vs Max Options Open Interest
JAZZ Max Change In Options Open Interest
JAZZ Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JAZZ Daily Out of Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JAZZ Daily In the Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JAZZ Most Active Options by Volume(near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Jazz Pharmaceuticals, Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.
JAZZ Moving Averages Analysis
Jazz Pharmaceuticals, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on May 13, 2026
Jazz Pharmaceuticals, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 13, 2026
JAZZ (Jazz Pharmaceuticals, Inc.) Simple Moving Averages
Moving Averages are last updated May 13, 2026
| Days | MA |
|---|---|
| 10 | 219.12 |
| 20 | 209.9 |
| 30 | 204.5 |
| 50 | 196.23 |
| 100 | 183.21 |
| 200 | 160.7 |
JAZZ Fundamental Analysis
| P/E (Forward) | 12.3153 |
| P/E (Trailing) | 2032.8182 |
| Market Cap ($) | 14.0 billion |
| Earnings/Share ($) | 0.11 |
| Net Proft Margin (%) | 0.0066 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 25.3151 |
| EPS Estimate Next Year ($) | 25.511 |
| WallStreet Target Price ($) | 241.7647 |
| Most Recent Quarter |